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ABSTRACT
Objective: To assess the correlation of tissue parameters estimated by quantitative magnetic res-
onance (MR) techniques and motor handicap in patients with hypomyelination.
Methods: Twenty-eight patients with different causes of hypomyelination (12 males, 16 females;
mean age 10 years) and 61 controls (33 males, 28 females; mean age 8 years) were prospec-
tively investigated. We quantified T2 relaxation time, magnetization transfer ratio, fractional
anisotropy, mean, axial, and radial diffusivities, and brain metabolites. We performed measure-
ments in the splenium, parietal deep white matter, and corticospinal tracts in the centrum semi-
ovale. We further analyzed diffusion measures using tract-based spatial statistics. We estimated
severity of motor handicap by the gross motor function classification system. We evaluated cor-
relation of handicap with MR measures by linear regression analyses.
Results: Fractional anisotropy, magnetization transfer ratio, choline, and N-acetylaspartate/creatine
ratio were lower and diffusivities, T2 values, and inositol were higher in patients than in controls.
Tract-based spatial statistics showed that these changes were widespread for fractional anisotropy
(96% of the white matter skeleton), radial (93%) and mean (84%) diffusivity, and less so for axial
diffusivity (20%). Correlation with handicap yielded radial diffusivity and N-acetylaspartate/creatine
ratio as strongest independent explanatory variables.
Conclusions: Gross motor function classification system grades are in part explained byMRmeas-
ures. They indicate that mainly lack of myelin and, to a lesser degree, loss of axonal integrity
codetermine the degree of motor handicap in patients with hypomyelinating disorders. These
MR measures can be used to evaluate strategies that are aimed at promotion of myelination.
Neurology® 2016;87:752–758
GLOSSARY
AD 5 axial diffusivity; CSI 5 chemical shift imaging; DTI 5 diffusion tensor imaging; FA 5 fractional anisotropy; GMFCS 5
gross motor function classification system;MD5mean diffusivity;MR5magnetic resonance;MTR5magnetization transfer
ratio; NAA 5 N-acetylaspartylglutamate; RD 5 radial diffusivity; ROI 5 region of interest; TBSS 5 tract-based spatial
statistics; TE 5 echo time; TFCE 5 threshold-free cluster enhancement; TR 5 repetition time; WM 5 white matter.
Quantitative magnetic resonance (MR) techniques provide information on histopathology of
brain white matter (WM) disorders.1–9 In this study, we focused on hypomyelinating disorders,
defined by permanent lack of myelin deposited. Hypomyelination can be diagnosed by MRI
based on a pattern of mildly hyperintense T2 signal (figure 1A) and mildly hypo-, iso-, or
hyperintense T1 signal of the WM relative to the cortex (figure 1B), depending on myelin
content.10 Follow-upMRI at least 6 months later and at an age older than 1 or preferably 2 years
should show no myelination progress.10
Clinically, hypomyelination is associated with variable handicap ranging from walking with-
out support and attending regular school to wheelchair dependency and absence of speech.11
The variation in handicap is unexplained; conventional MRI does not show clear differences in
myelin content. These observations bring into question the relative importance of myelin,
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especially compared to axonal integrity. Such
questions are fundamental when considering
therapies that are aimed at promotion of
myelination.12
Previous studies of quantitative MR in
hypomyelination showed that hypomyelinat-
ing disorders are generally characterized by
results that are close to normal.6,8 In the pres-
ent study, we aimed to assess the correlation of
tissue measures as estimated by quantitative
MR techniques and degree of motor handicap
in patients with hypomyelination with the
hypothesis that the myelin content, estimated
by quantitative MRI measures, codetermines
the severity of handicap. We included axial
diffusivity (AD) and radial diffusivity (RD)
because AD was found to correlate with axonal
integrity13,14 and RD with intactness of
myelin.15,16
METHODS Standard protocol approvals, registrations,
and patient consents. This prospective case-control study was
performed with approval of the institutional review board and
consent of patients and/or parents.
Participants. Between January 2007 and June 2011, 28 patients
(table 1) underwent MRI, who fulfilled the following inclusion
criteria: (1) DNA-proven hypomyelinating disorder, or (2) stable
substantial deficit in myelination on 2 consecutive MRIs with an
interval of at least 6 months and the second MRI in the second
year or later, or (3) severe deficit in myelination onMRI in a child
older than 2 years, making it unlikely that normal myelination
will ever be achieved.10 Four of these 28 patients had 2
quantitative MRIs during this period. The best quality and
most complete MRI was used for analysis; if the quality was
equal, the first was chosen. Using this strategy, the first MRI
was analyzed in 2 cases and the second in the other two.
Experienced investigators (N.I.W., M.S.v.d.K.) visually rated
the MRI scans. Twelve patients were male, 16 were female; age
range was 0.5 to 47 years (mean age 6 SD: 11.4 6 9.9 years).
None of the patients had other coexistent conditions that might
affect the brain WM. To obtain normative data, we included 61
individuals in the same age range who underwent MRI for other
reasons (mild developmental delay, autism, epilepsy, tics,
headache) and had a normal MRI and neurologic examination.
Thirty-three were male, 28 female; age range was 0.3 to 44 years
(mean age 6 SD: 7.9 6 9.4 years). Some control participants
underwent only part of the quantitative MRI protocol (table e-1
on the Neurology® Web site at Neurology.org).
MR acquisition. All studies were conducted on the same MR
machine at 1.5T (Siemens Sonata, Erlangen, Germany) with an
8-channel phased-array head coil. The conventional imaging
protocol included axial T2-weighted spin echo images, axial fluid-
attenuated inversion recovery images, and sagittal T1-weighted
images using a 3-dimensional magnetization-prepared rapid-
acquisition gradient echo sequence.
For MR spectroscopy with chemical shift imaging (CSI), we
used PRESS (point-resolved spectroscopy) (repetition time [TR]/
echo time [TE] 3,000/30 milliseconds [ms], 6 acquisitions with
weighted phase encoding) on a single 15-mm slice (field of view
120–160 3 160 mm2 depending on head size, volume of interest
60–803 100 mm2, 163 16 phase encodings, voxel size 7.5–103
10 3 15 mm3) centered onto the corpus callosum. Unsuppressed
water reference scans were obtained with head and body coil.17
For diffusion tensor imaging (DTI), we used a multislice echo
planar imaging sequence (TR/TE 6,700/81 ms, b value 750 s/mm2,
12 directions, 2 acquisitions, 1 b0 volume, 49 slices, pixel size 2.53
2.5 3 2.5 mm3, no parallel imaging). One of the slices corre-
sponded to the center of the CSI slice.
For T2 relaxometry, we used a Carr-Purcell-Meiboom-Gill
sequence to acquire images at 32 different echo times (TR
2,500 ms, TE 10.4–332.8 ms, spacing 10.4 ms, 5 slices, pixel
Figure 1 Examples of FA, RD, MTR map, T2 map, and CSI spectrum
Male patient, age 7 years, with Pelizaeus-Merzbacher disease: T2-weighted (A) and T1-weighted (B) MRIs, FAmap (C), and RDmap (D) at the level of the centrum
semiovale, MTRmap (E) and T2map (F) at the level of the CSI slice and CSI spectrum of one voxel in the parietal white matter (G). Matching images of a control,
age 8 years, are shown (H–N). Corresponding maps (in the same column) have identical center-window levels for visual comparison. On the T2-weighted image of
the patient, the signal of the corona radiata is less hyperintense than the surrounding white matter, suggestingmoremyelin deposition. This was not the case for
all patients. CSI 5 chemical shift imaging; FA 5 fractional anisotropy; MTR 5 magnetization transfer ratio; RD 5 radial diffusivity.
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size 1 3 1 3 5 mm3). The middle slice corresponded to the
center of the CSI slice.
For magnetization transfer imaging, we used a 3-dimensional
FLASH (fast low-angle shot) sequence obtaining 2 sets of images:
one with a magnetization transfer saturation pulse (7.68-ms
gaussian radiofrequency pulse 1,500 Hz off-resonance [Ms])
and one without (M0). Imaging measures included TR/TE 23/
4.7 ms, pixel size 1 3 1 3 4 mm3, and 32 slices, with one of the
slices corresponding to the center of the CSI slice.
Data processing and analysis. We quantified metabolite con-
centrations measured by CSI as described before using LCModel18;
metabolite concentrations were reported in millimole/liter. For
generation of pixel-wise T2 maps, we fitted the relaxation time
curves to a mono-exponential decay: S(t) 5 S(0) exp(2t/T2).
We created magnetization transfer ratio (MTR) maps according
to the equation MTR 5 1 2 (Ms/M0). We used the FMRIB
Software Library (http://www.fmrib.ox.ac.uk/fsl) to analyze DTI
data, resulting in maps of fractional anisotropy (FA), AD, RD,
and mean diffusivity (MD) (or apparent diffusion coefficient).
FA images from multiple participants were aligned into
a common space with tract-based spatial statistics (TBSS) and
a mean FA skeleton was created. Each participant’s aligned FA
data were projected onto this skeleton and fed into voxel-wise
cross-participant statistics using Randomize, with age as covariate.19
We estimated DTI measures and T2 and MTR values in 3
WM regions of interest (ROIs), representing different phases dur-
ing normal myelination: early myelination (corticospinal tracts in
the centrum semiovale), intermediate myelination (splenium),
and late myelination (parietal deep WM). The advantage of
including the splenium is that it does not contain fibers with dif-
ferent orientations (“crossing fibers”). DTI ROIs, positioned in
standard space, were identical for all participants. We manually
placed ROIs on T2 and MTR maps based on visual matching
with DTI ROIs. In some patients, the splenium was very thin,
hampering ROI positioning (table e-1). Regarding CSI, we
included voxels in the analyses that best corresponded to the
parietal deep WM ROIs, as well as voxels containing the cortico-
spinal tracts. The splenium of the corpus callosum was not pres-
ent in the CSI slab and therefore not included. Values of left and
right hemispheres were averaged. Using TBSS, we further evalu-
atedDTImeasures by estimating the percentage of theWM skeleton
that was significantly different from controls (threshold-free cluster
enhancement [TFCE]-corrected p, 0.01). For the voxels, in which
all DTI metrics were significantly different between patient and
control values, we extracted the DTI values and averaged them for
patients and controls.
Motor handicap. Because there is no standardized tool to assess
motor performance in hypomyelinating disorders, we used the
quantitative, validated, and widely used gross motor function
classification system (GMFCS)20 to score the severity of motor
handicap at the time of MRI to allow comparison of motor
function with quantitative MR measures. Two experienced in-
vestigators (M.E.S., N.I.W.) separately assessed patients based on
medical files.
To evaluate the correlation between GMFCS and quantita-
tive MR measures, we used the parietal deep WM ROI and the
ROI containing the corticospinal tracts in the centrum semiovale.
Statistical analysis. We constructed 3 datasets, one comprising
patient values, a second containing control values, and a third
with calculated control values age-matched per patient, based
on a mono-exponential fit through the control measures: a 1
b exp(2age/tau). Parameters a (limiting value), b (difference
between limiting value and value at age 0 years), and tau (time
constant) were estimated using nonlinear least squares (table e-2).
To assess whether the MRmeasures were significantly different
between patients and controls, we first removed the dependency on
age by subtraction of an isotonic regression curve fitted jointly (as
appropriate under the null hypothesis) on both groups. Subse-
quently, we used theWilcoxon rank sum test to compare the result-
ing age-corrected characteristics (residuals) of the 2 groups.
To evaluate a possible distinction between AD and RD, we
transformed the data of patients and controls to rank data fol-
lowed by fitting of an isotonic regression curve between the rank
data and age and obtaining the residual ranks from this analysis.
We used the Wilcoxon test to assess the significance of differences
between AD and RD.
We used linear regression analyses to correlate GMFCS and
quantitative MR measures. Missing MR measure data of patients
Table 1 Overview of the patients with hypomyelination
Patient Age at MRI, y Sex Cause
Method of
diagnosis GMFCS
1 10.3 M 4H DNA-based 2
2 17.6 F 4H DNA-based 2
3 19.3 F 4H DNA-based 5
4 1.5 M HABC DNA-based 5
5 2.8 F HABC DNA-based 3
6 5.9 F HABC DNA-based 4
7 10.6 M HCC DNA-based 4
8 13.3 M HCC DNA-based 4
9 47.2 F ODDD DNA-based 2
10 0.8 M PMD DNA-based 5
11 1.8 M PMD DNA-based 5
12 1.9 M PMD DNA-based 2
13 7.0 M PMD DNA-based 3
14 20.9 M PMD DNA-based 5
15 11.0 M PMLD DNA-based 4
16 0.5 F RARS DNA-based 4
17 2.4 F RARS DNA-based 3
18 16.8 M RARS DNA-based 4
19 4.1 F Salla DNA-based 4
20 4 F Unknown 5
21 5.4 F Unknown 1
22 5.4 F Unknown 1
23 7.3 F Unknown 1
24 12.6 M Unknown 2
25 14.7 M Unknown 2
26 15.6 F Unknown 1
27 27.4 F Unknown 5
28 30.5 F Unknown 1
Abbreviations: 4H 5 hypomyelination with hypogonadotropic hypogonadism and hypodon-
tia; GMFCS 5 gross motor function classification system; HABC 5 hypomyelination with
atrophy of the basal ganglia and cerebellum; HCC 5 hypomyelination with congenital cat-
aract; ODDD 5 oculodentodigital dysplasia; PMD 5 Pelizaeus-Merzbacher disease; PMLD 5
PMD-like disease; RARS 5 hypomyelination with RARS mutations.
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were imputed using a nonparametric k-nearest neighbor
method.21 First analysis comprised simple linear regression link-
ing handicap to individual measures. Subsequently, we built
a multiple linear regression model with a preference of the more
parsimonious model. Model search was performed in a backward
manner, first including all explanatory variables and then remov-
ing them one by one. We used selection frequency, based on
application of lasso regression to 1,000 resampled versions
of the dataset, as an inclusion criterion; cross-validation deter-
mined the lasso penalty measure. We chose the final model
to minimize the number of explanatory variables without com-
promising the coefficient of determination.
RESULTS Table e-1 presents the number of
included MR studies per quantitative method.
Figure 1 shows examples of the FA, RD, MTR
map, T2 map, and CSI spectrum. Figure e-1 shows
diagrams of MR measures vs age per WM area.
DTI, T2 relaxometry, and magnetization transfer imaging.
In the ROI analysis, FA was lower in patients than in
controls in all areas. Regional distribution was similar
in patients and controls: FA of the splenium was higher
than that of the otherWM areas. The decrease in FA in
patients relative to age-matched controls was also
largest in the splenium. AD, RD, and MD were
higher in patients than in controls. Patients had the
highest values of AD, RD, and MD in the splenium,
and differences for these measures compared with
controls were also largest in the splenium (figure e-1,
table 2). When AD and RD were compared, the
increase in RD was significantly greater relative to
age-matched control values than the increase in AD
(Wilcoxon rank sum test: p 5 0.008 for splenium;
p 5 0.027 for corticospinal tracts in the centrum
semiovale; p 5 0.002 for deep parietal WM). In all
WM areas, MTR values were lower in patients than in
controls (figure e-1, table 2), while T2 values were
higher.
For the TBSS analysis, we created a mean WM
skeleton, shown in green in figure 2. When we com-
pared DTI measures of patients with those of controls
within the skeleton, extensive changes in all DTI
measures were observed. FA was lower in patients
than in controls in as much as 96% of the whole
skeleton (TFCE-corrected threshold ,0.01). RD
was increased in 93% of the skeleton, and MD in
84% of the skeleton. AD was increased in only
20% of the skeleton. These latter areas were confined
to the splenium, small part of the genu, corona radi-
ata, parts of the superior longitudinal fasciculus, and
parts of the thalamic radiation (figure 2, D–F).
Table 3 shows mean values of the measures within
the area that was significantly abnormal for all DTI
metrics (20% of the skeleton; TFCE-corrected
threshold,0.01). Although all voxels within this area
had significantly increased AD, the relative increase in
AD of 13% was much smaller than the 35% increase
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in RD, in agreement with the significantly larger
increase of RD than AD in the ROI analysis.
Chemical shift imaging. CSI results were similar for the
parietal deep WM and corticospinal tracts in the cen-
trum semiovale. Choline (Cho)-containing compounds
were lower and myo-inositol (Ins) was higher in
patients than in controls. N-acetylaspartate, including
N-acetylaspartylglutamate (NAA), and creatine (Cr)
and phosphocreatine (Cr) mainly showed decreases
and increases, respectively (figure e-1, table 2). To
correct for possible effects of higher axonal density per
tissue volume caused by lower density of myelin sheaths
on NAA values, we also evaluated the ratio NAA/Cr.
NAA/Cr values were either normal or reduced in
patients compared with controls (figure e-1).
Motor handicap correlated with quantitative MR
measures. The motor handicap of the patients assessed
by the GMFCS is summarized in table 1. Regression
analyses of quantitative MR measures in the parietal
deep WM revealed MTR and RD as measures with
the largest coefficients of determination individually
(0.48 and 0.46, respectively); NAA/Cr (R2 0.37) and
T2 (R2 0.35) had reasonable coefficients of determi-
nation as well. The other measures did not correlate
well with motor handicap (R2: NAA 0.17, AD 0.13,
Ins 0.07, Cho 0.008, Cr 0). Multiple linear regression
analyses indicated that the most parsimonious model
included NAA/Cr and RD. MTR and T2 could be
added to the model but did not lead to improvement
of the coefficient of determination. Ins, Cho, and AD
did not add anything to the model. The final model
was given by GMFCS 5 0.33 1 6 3 103 3 RD 2
2.29 3 NAA/Cr with p values ,0.001 for RD and
,0.01 for NAA/Cr (Student t test). The model ex-
plained 58% of the variance in GMFCS.
Analysis with the results of the quantitative MR
measures in the ROI containing the corticospinal
tracts yielded a final model that expressed GMFCS
in terms of RD and NAA/Cr as well, with 51% of var-
iance explained.
DISCUSSION Our aim was to gain insight into tissue
measures that account for unexplained variability in
motor handicap among patients with hypomyelina-
tion, which could serve to monitor future therapies.
The changes we found in quantitative MR measures
in the WM are in line with lack of myelin, with
low FA, high RD and AD, high T2 relaxation times,
low MTR, and low Cho, and to a lesser degree with
compromised axonal integrity with slightly elevated
AD and decreased NAA/Cr. The variation in
GMFCS was in part (58%) explained by the measures
obtained in the parietal deep WM; the results for the
area containing the corticospinal tracts were similar.
Individually, RD, NAA/Cr, MTR, and T2 all corre-
lated with GMFCS; NAA/Cr and RD were the stron-
gest independent predictors.
Measurements of AD and RD in hypomyelination
have not been reported previously. RD has been sug-
gested to correlate with amounts and integrity of
myelin15,16 and AD with axonal integrity.13,14 Because
the interpretation of AD and RD in crossing fiber
regions requires caution,22 we also included the sple-
nium. RD had the strongest correlation with
GMFCS; AD showed a much weaker correlation.
The increase in RD was larger and much more wide-
spread than the change in AD (93% vs 20% of the
skeleton), with a normal AD in large areas in which
Figure 2 TBSS images
TBSS images depicting (A) decreased fractional anisotropy (red), (B) increased radial
diffusivity (yellow), (C) increased mean diffusivity (yellow), and (D–F) increased axial
diffusivity (yellow) at threshold-free cluster enhancement–corrected p , 0.01 in patients
with hypomyelination vs controls overlaid on skeleton (green). TBSS 5 tract-based spatial
statistics.
Table 3 DTI measures in patients with hypomyelination and controls within the
part of the white matter skeleton that is abnormal for all DTI metrics
(20% of the skeleton)
MR measure Patients Controls
Absolute
difference
Relative
difference, %
FA 0.31 (0.05) 0.40 (0.05) 20.09 224
MD, 1025 mm2/s 115 (15) 93 (11) 23 24
AD, 1025 mm2/s 154 (15) 135 (9) 18 13
RD, 1025 mm2/s 97 (16) 72 (12) 25 35
Abbreviations: AD 5 axial diffusivity; DTI 5 diffusion tensor imaging; FA 5 fractional anisot-
ropy; MD 5 mean diffusivity; MR 5 magnetic resonance; RD 5 radial diffusivity.
Data represent mean (SD) or mean. MR measures were significantly different between
patients and controls at a threshold-free cluster enhancement–corrected threshold ,0.01.
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conventional images indicate lack of myelin. DTI
measures in the splenium were distinct from DTI
measures in the other WM regions in that the differ-
ences between patients and controls were larger.
Partial volume effects with inclusion of CSF in the
ROIs may explain these findings, as in many patients
the splenium had reduced thickness. Partial volume
correction by the method of free water elimination
might reduce this problem in future studies.23,24
MTR has been interpreted as a measure represent-
ing myelin integrity, although it has also been corre-
lated with axonal integrity.25 In our study, MTR
alone correlated strongly with GMFCS, but was not
selected as an independent explanatory variable.
MTR is correlated with RD and NAA/Cr, and in
the regression analysis, the combination of these latter
2 variables yielded the most parsimonious model
without a significant extra contribution of MTR.
NAA was low to normal in the WM of patients.
NAA, although synthesized and degraded in glia, is
mainly located in neurons and axons and is a useful sur-
rogate marker for axonal integrity and density.26,27 The
relatively normal NAA in some patients could be inter-
preted as evidence of relative axonal integrity, but the
explanation is more complex. High WM concentrations
of NAA have been reported before in hypomyelina-
tion,28 probably reflecting higher axonal density in the
absence of normal myelin density. Dividing NAA by Cr,
reflecting cell density in general, corrects at least partially
for higher compaction due to lack of myelin. Whereas
NAA and Cr individually did not correlate with the
GMFCS, NAA/Cr did, suggesting that axonal damage
does contribute to the motor handicap in hypomyelinat-
ing disorders, although to a lesser degree than lack of
myelin considering the relatively small change in AD.
The above results are in line with existing evidence
that RD is correlated inversely with amount and
integrity of myelin and indicate that myelin is a stron-
ger determiner of handicap in patients with hypomye-
lination than axonal integrity.
All odds were against this study with a rather small
number of patients, heterogeneous diagnoses each
associated with private effects on handicap and MR
measures, large patient age variation, acquisition of
quantitative MR measures in only 3 brain areas, and
the neurologic health of controls not being
fully guaranteed. Hypomyelinating disorders are very
rare diseases with many different known and often
unknown causes.10,29 A group of 28 patients investi-
gated on one MR system is actually large. Ideally, only
healthy participants would be included as controls, but
this is not an option for very young children who need
anesthesia or sedation. Despite normal neurologic
examination and MRI, the controls had some com-
plaints and their quantitative measures were probably
more variable than in completely healthy participants.
The fact that we did find a correlation between quan-
titativeMRmeasures and the severity of motor handicap
despite these odds corroborates the results. Because we
found this correlation in a group of hypomyelinating dis-
orders with different causes and underlying pathologies,
it is likely that the correlation would be even stronger in
studies on single hypomyelinating disorders. That we
found this correlation while comparing patients with
control subjects with some neurologic complaints indi-
cates that the correlation may actually be stronger. The
correlation between quantitative brain MR measures
and clinical handicap was found, while only 3 brain areas
were investigated. If more areas, especially brainstem and
spinal cord tracts would be included, the correlation
would increase. Future longitudinal studies including
more extensive serial MRI measurements and clinical
follow-up should give the opportunity to further support
the results of the present cross-sectional study.
Hypomyelinating disorders constitute a large frac-
tion of the leukodystrophies, for which therapies are
urgently needed. The fact that measures representing
myelin integrity (RD) show a stronger correlation
with motor handicap than measures of axonal integ-
rity (NAA/Cr, AD) is a highly promising finding in
view of strategies aimed at promotion of myelination.
Objective measures to evaluate the success of novel
therapies, such as neural stem cell engraftment,30
are necessary. Our study indicates that quantitative
MR can be useful to monitor outcome.
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